MCM
ONC

McKinley Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

McKinley Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15,472
Closed -$4.19M – 190
2021
Q4 		$4.19M Sell
15,472
-194
-1% -$65.5K 0.37% 84
2021
Q3 		$5.69M Sell
15,666
-7,539
-32% -$2.46M 0.54% 64
2021
Q2 		$7.96M Sell
23,205
-2,490
-10% -$825K 0.56% 55
2021
Q1 		$8.94M Sell
25,695
-61
-0.2% -$20.2K 0.67% 49
2020
Q4 		$6.66M Sell
25,756
-129
-0.5% -$35.5K 0.47% 63
2020
Q3 		$7.41M Sell
25,885
-3,845
-13% -$904K 0.58% 50
2020
Q2 		$5.6M Sell
29,730
-566
-2% -$92.1K 0.38% 61
2020
Q1 		$3.73M Buy
30,296
+25,617
+547% +$4.01M 0.3% 73
2019
Q4 		$775K Sell
4,679
-271
-5% -$45K 0.05% 159
2019
Q3 		$607K Buy
+4,950
New +$657K 0.05% 143

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

McKinley Capital Management's ONC Position: Q1 2022 in Review

McKinley Capital Management sold out of BeOne Medicines Ltd (ONC) in Q1 2022, closing a stake of 15,472 shares — an estimated $4.19M sold.

McKinley Capital Management first reported a position in ONC in Q3 2019 and held it in 10 quarters. The position peaked at $8.94M in Q1 2021. 239 funds tracked by Wall St. Rank hold ONC as of Q1 2022.

  • McKinley Capital Management reported no remaining BeOne Medicines Ltd position as of Q1 2022 after selling out during the quarter.
  • McKinley Capital Management sold 15,472 BeOne Medicines Ltd shares in Q1 2022, an estimated $4.19M.
  • McKinley Capital Management first reported a position in BeOne Medicines Ltd in Q3 2019 and held it in 10 quarters.
  • McKinley Capital Management's BeOne Medicines Ltd position peaked at $8.94M in Q1 2021.
  • 239 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2022.

Based on McKinley Capital Management's 13F filing for Q1 2022, filed 29 Apr 2022.